Since PTEN is known as a lipid phosphatase that antagonizes the PI3K/AKT signaling pathway [7], we next treated prostate cancer cell lines PC3 and/or LNCaP cells with PI3K inhibitor LY294002 for hours as indicated. The gene discussed is AKT1; the disease is prostate carcinoma.